Determining the antidepressant effect of 2-bromo-LSD (TD-0148A)
We would like to determine whether a modified version of LSD (TD-0148A), which does not induce hallucinations, has antidepressant effects that can be applied to patients with depressive disorders. We will investigate whether TD-0148A can change the physical structure of neurons, as other antidepressants do. Furthermore, we will use an animal model to determine whether TD-0148A can reverse the negative effects of chronic stress, whish is a leading cause of depression in people. These findings can represent a breakthrough in depression treatment, as TD-0148A has a better safety profile compared to LSD and other drugs that induce hallucinations.
View Full Project DescriptionArgel Aguilar Valles
BetterLife Pharma Inc
Life Sciences
Professional, scientific and technical services
Carleton University
Accelerate